No photo of Charles Ryan
Contact Expert

View Scopus Profile

Charles Ryan

20002020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 1 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

INTense Exercise foR surVivAL among men with Metastatic Castrate-Resistant Prostate Cancer (INTERVAL??? MCRPC): A Multicentre, Randomised, Controlled, Phase III Study

Ryan, C.

Movember Foundation

7/2/20 → 5/31/24

Project: Research project

    • CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone (A Phase 2 Study of Carboplatin, Cabazitaxel and Abiraterone in Metastatic Castrate Sensitive Prostate Cancer with and without DNA repair mutations)

    Ryan, C.

    PROSTATE CANCER CLINTRIAL CONSORTIUM LLC

    1/1/19 → 12/30/22

    Project: Research project

    • Cognitive Effects of Androgen Receptor (AR) Directed Therapies for Advanced Prostate Cancer.

    Ryan, C.

    Northwestern University

    8/31/18 → 8/22/20

    Project: Research project

    • Survivorship Enhancement in Men with prostate cancer at Risk for Poor Cognitive Health During Treatmentwith ADT (SEARCH)

    Ryan, C.

    Prostate Cancer Foundation

    4/30/18 → 12/31/20

    Project: Research project

    • A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician'sChoice of Therapy for Patients with Metastatic Castration resistant Prostate Cancer Associated withHomologous Recombination Deficiency

    Ryan, C.

    CLOVIS ONCOLOGY, INC.

    4/1/18 → 4/30/23

    Project: Research project

    • Research Output

    Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)

    From The Alliance for Clinical Trials in Oncology Genitourinary Committee, Mar 1 2020, In : Prostate Cancer and Prostatic Diseases. 23, 1, p. 66-73 8 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations

    Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel

    The Alliance for Clinical Trials in Oncology Genitourinary Committee, Jun 2020, In : Clinical Genitourinary Cancer. 18, 3, p. 222-229.e2

    Research output: Contribution to journal › Article

    • A review of prostate cancer treatment impact on the CNS and cognitive function

    Ryan, C., Wefel, J. S. & Morgans, A. K., Jun 1 2020, In : Prostate Cancer and Prostatic Diseases. 23, 2, p. 207-219 13 p.

    Research output: Contribution to journal › Review article

    Open Access

    • Diet and lifestyle considerations for patients with prostate cancer

    Zuniga, K. B., Chan, J. M., Ryan, C. J. & Kenfield, S. A., Mar 2020, In : Urologic Oncology: Seminars and Original Investigations. 38, 3, p. 105-117 13 p.

    Research output: Contribution to journal › Review article

    • 1 Scopus citations

    Editorial: Androgen hazards with COVID-19

    Sharifi, N. & Ryan, C. J., Jan 1 2020, In : Endocrine-related cancer. 27, 6, p. E1-E3

    Research output: Contribution to journal › Review article

    Open Access
    1 Scopus citations

    Press / Media

    Cancer death rates are going down. Is prostate cancer an exception?

    Charles Ryan

    2/4/20

    1 item of Media coverage

    Press/Media: Expert Comment